is everyone on a glp 1 The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 GLP-1 Agonists - What is
Description
Large meals should be avoided since these medications slow down stomach emptying, which can make discomfort worse

Takenaka K, Nishitani R

doi: 10.1038/s41598-022-06463-6
While these clinical studies documented only moderate and heterogeneous effects of GLP-1RAs on lean body mass, rodent studies have demonstrated a reduction of visceral adipose tissue and upregulation of browning-related genes in subcutaneous white adipose tissue, which can lead to a stimulation of energy expenditure by upregulated thermogenesis [79, 109, 110]
Labeling update (2026): The FDA recently removed suicidal behavior and ideation language from the labeling of certain GLP-1 medicines used for chronic weight management, following a comprehensive safety review that found no evidence of increased risk